Enhanced	0	8	O
expression	9	19	O
of	20	22	O
vascular	23	31	B-Gene_or_gene_product
endothelial	32	43	I-Gene_or_gene_product
growth	44	50	I-Gene_or_gene_product
factor	51	57	I-Gene_or_gene_product
by	58	60	O
periodontal	61	72	B-Organism_subdivision
pathogens	73	82	O
in	83	85	O
gingival	86	94	B-Cell
fibroblasts	95	106	I-Cell
.	106	107	O

Vascular	109	117	B-Gene_or_gene_product
endothelial	118	129	I-Gene_or_gene_product
growth	130	136	I-Gene_or_gene_product
factor	137	143	I-Gene_or_gene_product
(	144	145	O
VEGF	145	149	B-Gene_or_gene_product
)	149	150	O
has	151	154	O
recently	155	163	O
attracted	164	173	O
attention	174	183	O
as	184	186	O
a	187	188	O
potent	189	195	O
inducer	196	203	O
of	204	206	O
vascular	207	215	B-Multi-tissue_structure
permeability	216	228	O
and	229	232	O
angiogenesis	233	245	O
.	245	246	O

Aberrant	247	255	O
angiogenesis	256	268	O
is	269	271	O
often	272	277	O
associated	278	288	O
with	289	293	O
lesion	294	300	B-Pathological_formation
formation	301	310	O
in	311	313	O
chronic	314	321	O
periodontitis	322	335	O
.	335	336	O

The	337	340	O
aim	341	344	O
of	345	347	O
the	348	351	O
present	352	359	O
study	360	365	O
was	366	369	O
to	370	372	O
investigate	373	384	O
the	385	388	O
properties	389	399	O
of	400	402	O
VEGF	403	407	B-Gene_or_gene_product
expression	408	418	O
in	419	421	O
human	422	427	B-Organism
gingival	428	436	B-Cell
fibroblasts	437	448	I-Cell
(	449	450	O
HGF	450	453	B-Cell
)	453	454	O
culture	455	462	O
.	462	463	O

HGF	464	467	B-Cell
were	468	472	O
stimulated	473	483	O
with	484	488	O
lipopolysaccharide	489	507	B-Drug_or_compound
(	508	509	O
LPS	509	512	B-Drug_or_compound
)	512	513	O
,	513	514	O
vesicle	515	522	B-Cellular_component
(	523	524	O
Ve	524	526	B-Cellular_component
)	526	527	O
and	528	531	O
outer	532	537	B-Gene_or_gene_product
membrane	538	546	I-Gene_or_gene_product
protein	547	554	I-Gene_or_gene_product
(	555	556	O
OMP	556	559	B-Gene_or_gene_product
)	559	560	O
from	561	565	O
Actinobacillus	566	580	B-Organism
actinomycetemcomitans	581	602	I-Organism
and	603	606	O
Porphyromonas	607	620	B-Organism
gingivalis	621	631	I-Organism
.	631	632	O

HGF	633	636	B-Cell
constitutively	637	651	O
produced	652	660	O
VEGF	661	665	B-Gene_or_gene_product
and	666	669	O
levels	670	676	O
were	677	681	O
significantly	682	695	O
enhanced	696	704	O
(	705	706	O
P	706	707	O
less	709	713	O
than	714	718	O
0	720	721	O
.	721	722	O
01	722	724	O
)	724	725	O
by	726	728	O
stimulation	729	740	O
with	741	745	O
Ve	746	748	B-Cellular_component
and	749	752	O
OMP	753	756	B-Gene_or_gene_product
from	757	761	O
A	762	763	B-Organism
.	763	764	I-Organism
actinomycetemcomitans	765	786	I-Organism
and	787	790	O
P	791	792	B-Organism
.	792	793	I-Organism
gingivalis	794	804	I-Organism
at	805	807	O
concentrations	808	822	O
of	823	825	O
10	826	828	O
microg	829	835	O
/	835	836	O
ml	836	838	O
or	839	841	O
higher	842	848	O
.	848	849	O

On	850	852	O
the	853	856	O
other	857	862	O
hand	863	867	O
,	867	868	O
VEGF	869	873	B-Gene_or_gene_product
levels	874	880	O
were	881	885	O
not	886	889	O
increased	890	899	O
by	900	902	O
LPS	903	906	B-Drug_or_compound
stimulation	907	918	O
.	918	919	O

VEGF	920	924	B-Gene_or_gene_product
mRNA	925	929	O
expression	930	940	O
was	941	944	O
also	945	949	O
observed	950	958	O
in	959	961	O
Ve	962	964	B-Cellular_component
-	964	965	O
and	966	969	O
OMP	970	973	B-Gene_or_gene_product
-	973	974	O
stimulated	974	984	O
HGF	985	988	B-Cell
.	988	989	O

A	990	991	O
vascular	992	1000	B-Multi-tissue_structure
permeability	1001	1013	O
enhancement	1014	1025	O
(	1026	1027	O
VPE	1027	1030	O
)	1030	1031	O
assay	1032	1037	O
was	1038	1041	O
performed	1042	1051	O
using	1052	1057	O
guinea	1058	1064	B-Organism
pigs	1065	1069	I-Organism
to	1070	1072	O
ascertain	1073	1082	O
whether	1083	1090	O
supernatant	1091	1102	O
from	1103	1107	O
cultures	1108	1116	O
of	1117	1119	O
Ve	1120	1122	B-Cellular_component
-	1122	1123	O
and	1124	1127	O
OMP	1128	1131	B-Gene_or_gene_product
-	1131	1132	O
stimulated	1132	1142	O
HGF	1143	1146	B-Cell
enhance	1147	1154	O
vascular	1155	1163	B-Multi-tissue_structure
permeability	1164	1176	O
in	1177	1179	O
vivo	1180	1184	O
.	1184	1185	O

Supernatant	1186	1197	O
from	1198	1202	O
cultures	1203	1211	O
of	1212	1214	O
Ve	1215	1217	B-Cellular_component
-	1217	1218	O
and	1219	1222	O
OMP	1223	1226	B-Gene_or_gene_product
-	1226	1227	O
stimulated	1227	1237	O
HGF	1238	1241	B-Cell
strongly	1242	1250	O
induced	1251	1258	O
VPE	1259	1262	O
.	1262	1263	O

This	1264	1268	O
was	1269	1272	O
markedly	1273	1281	O
suppressed	1282	1292	O
upon	1293	1297	O
simultaneous	1298	1310	O
injection	1311	1320	O
of	1321	1323	O
anti	1324	1328	O
-	1328	1329	O
VEGF	1329	1333	B-Gene_or_gene_product
polyclonal	1334	1344	O
antibodies	1345	1355	O
with	1356	1360	O
the	1361	1364	O
supernatant	1365	1376	O
.	1376	1377	O

Heating	1378	1385	O
and	1386	1389	O
protease	1390	1398	O
treatment	1399	1408	O
of	1409	1411	O
the	1412	1415	O
stimulants	1416	1426	O
reduced	1427	1434	O
the	1435	1438	O
VEGF	1439	1443	B-Gene_or_gene_product
enhancing	1444	1453	O
levels	1454	1460	O
in	1461	1463	O
Ve	1464	1466	B-Cellular_component
and	1467	1470	O
OMP	1471	1474	B-Gene_or_gene_product
in	1475	1477	O
vitro	1478	1483	O
.	1483	1484	O

These	1485	1490	O
results	1491	1498	O
suggest	1499	1506	O
that	1507	1511	O
Ve	1512	1514	B-Cellular_component
and	1515	1518	O
OMP	1519	1522	B-Gene_or_gene_product
may	1523	1526	O
be	1527	1529	O
crucial	1530	1537	O
heat	1538	1542	O
-	1542	1543	O
labile	1543	1549	O
and	1550	1553	O
protease	1554	1562	O
-	1562	1563	O
sensitive	1563	1572	O
components	1573	1583	O
of	1584	1586	O
periodontal	1587	1598	B-Organism_subdivision
pathogens	1599	1608	O
that	1609	1613	O
enhance	1614	1621	O
VEGF	1622	1626	B-Gene_or_gene_product
expression	1627	1637	O
.	1637	1638	O

In	1639	1641	O
addition	1642	1650	O
,	1650	1651	O
VEGF	1652	1656	B-Gene_or_gene_product
might	1657	1662	O
be	1663	1665	O
associated	1666	1676	O
with	1677	1681	O
the	1682	1685	O
etiology	1686	1694	O
of	1695	1697	O
periodontitis	1698	1711	O
in	1712	1714	O
its	1715	1718	O
early	1719	1724	O
stages	1725	1731	O
according	1732	1741	O
to	1742	1744	O
neovascularization	1745	1763	O
stimulated	1764	1774	O
by	1775	1777	O
periodontal	1778	1789	B-Organism_subdivision
pathogens	1790	1799	O
causing	1800	1807	O
swelling	1808	1816	O
and	1817	1820	O
edema	1821	1826	B-Pathological_formation
.	1826	1827	O

